IMPT vs IMRT for Nonmetastatic Nasopharyngeal Carcinoma

Journal club presentation on toxicity profiles and survival outcomes comparing intensity-modulated proton therapy vs intensity-modulated radiation therapy

Hypoxia-Directed Treatment of HPV-Related Oropharyngeal Carcinoma

Journal club presentation on the 30 ROC trial by Lee et al., JCO 2024

Prostate Cancer Trials: Salvage/Adjuvant and Oligometastatic Disease

Board review presentation covering key trials in salvage/adjuvant radiation and oligometastatic prostate cancer

GOG 99: Surgery with or without Adjunctive External Pelvic Radiation Therapy in Intermediate Risk Endometrial Adenocarcinoma

A presentation of the Gynecologic Oncology Group phase III trial comparing surgery alone versus surgery with adjuvant pelvic radiation therapy in intermediate risk endometrial cancer

PORTEC-3: Adjuvant Chemoradiotherapy versus Radiotherapy Alone for Women with High-Risk Endometrial Cancer

Journal club presentation on the international, open-label, phase 3 randomised PORTEC-3 trial

Modern LINAC-Based Radiotherapy for Pituitary Adenomas

Journal club presentation on outcomes of modern linear accelerator-based radiotherapy for secretory and nonsecretory pituitary adenomas

Conformal Radiation Therapy for Pediatric Ependymoma: The ACNS0121 Trial

Journal club presentation on the Children's Oncology Group ACNS0121 phase 3 trial for pediatric ependymoma

Conformal Radiation Therapy for Pediatric Ependymoma: The ACNS0121 Trial

Journal club presentation on the Children's Oncology Group ACNS0121 phase 3 trial for pediatric ependymoma

High-dose Proton Beam Therapy vs Conventional Radiation Therapy for Newly Diagnosed Glioblastoma

Journal club presentation of Matsuda et al. Radiation Oncology (2023) 18:38

Joint Final Report of EORTC 26951 and RTOG 9402: PCV Chemotherapy for Anaplastic Oligodendroglial Tumors

Journal club presentation on the final very long-term survival results of two phase III trials for anaplastic oligodendroglial tumors

Outcomes of stereotactic body radiotherapy 60 Gy in 8 fractions when prioritizing organs at risk for central and ultracentral lung tumors

Journal club presentation on Zhao et al. Radiation Oncology 2020

Targeting Beyond the Tumor: Radiation's Evolving Role in Oncogene-Driven Lung Cancer

Explore the exciting advancements in targeted therapies for oncogene-driven lung cancer, highlighting novel approaches and trial results that promise to redefine treatment strategies and improve patient outcomes. Discover what the future holds!

VISION Trial: QOL and Pain Outcomes with [177Lu]Lu-PSMA-617 in mCRPC

Journal club presentation on quality of life outcomes from the VISION phase 3 trial

Treatment Options for Low & Favorable Intermediate Risk Prostate Cancer - Part 1

Evidence-based review of management options - surgical management and early trials

ARTDECO: Dose Escalation in Definitive Chemoradiation for Esophageal Cancer

Journal club presentation on the ARTDECO phase 3 randomized trial

AHOD0431: PET-adapted therapy for early-stage, low-risk pediatric Hodgkin lymphoma

AHOD0431 trial, exploring PET-adapted therapy for low-risk pediatric Hodgkin lymphoma, with insights into patient outcomes, relapse patterns, and comparisons to existing studies.

AHL2011: PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma

Journal club presentation on the AHL2011 phase 3 randomized trial

Radiation Therapy for Localized MALT Lymphoma: Long-Term Outcomes

Journal club presentation on a prospective trial of radiation therapy for localized mucosa-associated lymphoid tissue (MALT) lymphoma

FoRT Trial: 4 Gy vs 24 Gy Radiotherapy for Follicular and Marginal Zone Lymphoma

Journal Club Presentation on the FoRT Trial by Hoskin et al.

Postoperative Chemoradiation for High-Risk Head and Neck Cancer

A comparative analysis of EORTC #22931 and RTOG #9501 trials

deck

Copy of deck

deck

deck